Skip to main content

Table 1 Demographic and clinical characteristics of 174 renal transplant recipients with mucormycosis

From: Mucormycosis in renal transplant recipients: review of 174 reported cases

Feature

All patients

Proportion of patients who died

Mean age, y

45.9 (range 11–70)

 

Gender

 Male

133(76%)

58/133 (43.6%)

 Female

41(24%)

16/41 (39.0%)

Underlying conditions

 No

30/174 (25.1%)

15/30 (50.0%)

 Diabetes

75/174 (43.1%)

25/75 (33.3%)

 Other conditionsa

19/174 (3.4%)

7/19 (36.8%)

 Not reported

50/174 (28.7%)

27/50 (54.0%)

Transplanted organs

 Kidney alone

162/174(93.1%)

71/162(43.8%)

 Kidney combined with other organs

12/174(6.9%)

9/12(75.0%)

Anti-allograft rejection therapy

 Yes

33/174(18.97%)

12/33(36.4%)

 No

16/174(9.1%)

7/16(43.8%)

 Not reported

125/174(71.8%)

55/125(44.0%)

Induction therapy

 Yes

33/174(19.0%)

12/33(36.4%)

 No

16/174(9.2%)

7/16(43.8%)

 Not reported

125/174(71.8%)

55/125(71.8%)

Reduce immunosuppressive drugs

 Yes

98(56.3%)

38/98(38.8%)

 No

6(3.4%)

2/6(33.3%)

 Not reported

70(40.2%)

34/70(48.6%)

Diagnostic methods

 Histopathology only

72/174(41.4%)

33/72(45.8%)

 Culture only

25/174(14.4%)

9/25(36.0%)

 Histopathology and culture

77/174(44.3%)

32/77(41.6%)

  1. aIncluding surgery, dental extraction, HIV infection, malignancy, trauma, and deferoxamine therapy